Senexin C
Product Specifications
CAS Number
2375554-02-0
Target
CDK
Related Pathways
Cell Cycle/Checkpoint
Purity
0.9806
Bioactivity
Senexin C is a novel orally active and specific CDK8/19 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.
Smiles
N#CC=1C=CC2=NC=CC(NCCC=3C=CC4=CC(=CC=C4C3)C(=O)N5CCN(C)CC5)=C2C1
Molecular Formula
C28H27N5O
Molecular Weight
449.55
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2269-82G1 100 µg
CD19 (CD19 Antigen, B Lymphocyte Antigen CD19, B Lymphocyte Surface Antigen B4, B4, Differentiation Antigen CD19, Leu 12, Leu-12, MGC12802) discontinued
Ask
View Details 
V2121-88E 100 µg
Vesicular Monoamine Transporter 1, Human (VMAT1) (Control Peptide)
Ask
View Details